Nikko Asset Management Americas, Inc. Recursion Pharmaceuticals, Inc. Transaction History
Nikko Asset Management Americas, Inc.
- $9.43 Billion
- Q2 2025
A detailed history of Nikko Asset Management Americas, Inc. transactions in Recursion Pharmaceuticals, Inc. stock. As of the latest transaction made, Nikko Asset Management Americas, Inc. holds 8,167,745 shares of RXRX stock, worth $38.1 Million. This represents 0.44% of its overall portfolio holdings.
Number of Shares
8,167,745
Previous 8,407,334
2.85%
Holding current value
$38.1 Million
Previous $44.5 Million
7.07%
% of portfolio
0.44%
Previous 0.6%
Shares
17 transactions
Others Institutions Holding RXRX
# of Institutions
367Shares Held
288MCall Options Held
7.76MPut Options Held
6.19M-
Vanguard Group Inc Valley Forge, PA36.1MShares$168 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl33MShares$154 Million1.38% of portfolio
-
Baillie Gifford & CO24.2MShares$113 Million0.1% of portfolio
-
Black Rock Inc. New York, NY17.3MShares$80.7 Million0.0% of portfolio
-
Softbank Group Corp Minato Ku Tokyo, M014.7MShares$68.4 Million0.31% of portfolio
About RECURSION PHARMACEUTICALS, INC.
- Ticker RXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 180,480,000
- Market Cap $841M
- Description
- Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...